Intracranial Metastases of Intramedullary Spinal Cord Low-Grade Astrocytoma

Abstract

This paper reports a case of intramedullary spinal cord low-grade (LG) astrocytoma that developed brain metastases after 21 months. A 6-year-old child presented with lower spine pain and falls during daily activity. A spinal cord mass was detected using spinal magnetic resonance imaging (MRI), and brain MRI was normal. The spinal lesion was partially resected, and pathological findings revealed LG astrocytoma (WHO Grade II). The patient underwent thoracolumbar radiotherapy. He returned 21 months following initial admission with symptoms of nausea, vomiting, headaches, and seizure. Brain MRI revealed multiple intracranial masses at the posterior fossa, left lateral ventricle, cerebellopontine angles, and left Meckel cave. A recurrent lesion was detected in the thoracic and lumbar regions of the spinal cord and in the cauda equina. The patient underwent chemotherapy. This rare case warns practitioners to monitor closely the cases of spinal cord astrocytoma that are diagnosed as LG tumors based on histology.

Keywords

Intracranial metastases - low-grade astrocytoma - pediatric - spinal cord tumor

Publication History

Received: 23 March 2018

Accepted: 21 June 2018

Article published online:
23 May 2021

• References

• 1 Luksik AS, Garzon-Muvdi T, Yang W, Huang J, Jallo GI. Pediatric spinal cord astrocytomas: A retrospective study of 348 patients from the SEER database. J Neurosurg Pediatr 2017; 19: 711-9
• 2 Ryu SJ, Kim JY, Kim KH, Park JY, Kuh SU, Chin DK. et al. A retrospective observational study on the treatment outcomes of 26 patients with spinal cord astrocytoma including two cases of malignant transformation. Eur Spine J 2016; 25: 4067-79
• 3 Jeong SM, Chung YG, Lee JB, Shin IY. Intracranial dissemination from spinal cord anaplastic astrocytoma. J Korean Neurosurg Soc 2010; 47: 68-70
• 4 Jang SY, Kong MH, Song KY, Frazee JG. Intracranial metastases of cervical intramedullary low-grade astrocytoma without malignant transformation in adult. J Korean Neurosurg Soc 2009; 45: 381-5
• 5 Minehan KJ, Shaw EG, Scheithauer BW, Davis DL, Onofrio BM. Spinal cord astrocytoma: Pathological and treatment considerations. J Neurosurg 1995; 83: 590-5
• 6 Seki T, Hida K, Yano S, Aoyama T, Koyanagi I, Sasamori T. et al. Clinical factors for prognosis and treatment guidance of spinal cord astrocytoma. Asian Spine J 2016; 10: 748-54
• 7 Fakhreddine MH, Mahajan A, Penas-Prado M, Weinberg J, McCutcheon IE, Puduvalli V. et al. Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. Neuro Oncol 2013; 15: 406-12
• 8 Peraud A, Herms J, Schlegel J, Müller P, Kretzschmar H, Tonn JC. et al. Recurrent spinal cord astrocytoma with intraventricular seeding. Childs Nerv Syst 2004; 20: 114-8
• 9 Elsamaloty H, Zenooz NA, Mossa-Basha M. Glioblastoma multiforme (GBM) of the conus medullaris with brain and brain stem metastases. Eur J Radiol Extra 2006; 58: 59-62
• 10 Abel TJ, Chowdhary A, Thapa M, Rutledge JC, Geyer JR, Ojemann J. et al. Spinal cord pilocytic astrocytoma with leptomeningeal dissemination to the brain. Case report and review of the literature. J Neurosurg 2006; 105: 508-14
• 11 Yamagami T, Kikuchi H, Higashi K, Goto Y, Imataka K. Intracranial metastasis of a spinal cord astrocytoma – Case report. Neurol Med Chir (Tokyo) 1990; 30: 69-73
• 12 Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW. et al. Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg 1995; 83: 67-71
• 13 Inoue T, Endo T, Nakamura T, Shibahara I, Endo H, Tominaga T. et al. Expression of CD133 as a putative prognostic biomarker to predict intracranial dissemination of primary spinal cord astrocytoma. World Neurosurg 2018; 110: e715-26
• 14 Bell WO, Packer RJ, Seigel KR, Rorke LB, Sutton LN, Bruce DA. et al. Leptomeningeal spread of intramedullary spinal cord tumors. Report of three cases. J Neurosurg 1988; 69: 295-300
• 15 Perilongo G, Garrè ML, Giangaspero F. Low-grade gliomas and leptomeningeal dissemination: A poorly understood phenomenon. Childs Nerv Syst 2003; 19: 197-203
• 16 Winograd E, Pencovich N, Yalon M, Soffer D, Beni-Adani L, Constantini S. et al. Malignant transformation in pediatric spinal intramedullary tumors: Case-based update. Childs Nerv Syst 2012; 28: 1679-86
• 17 Scheinemann K, Bartels U, Huang A, Hawkins C, Kulkarni AV, Bouffet E. et al. Survival and functional outcome of childhood spinal cord low-grade gliomas. Clinical article. J Neurosurg Pediatr 2009; 4: 254-61
• 18 Townsend N, Handler M, Fleitz J, Foreman N. Intramedullary spinal cord astrocytomas in children. Pediatr Blood Cancer 2004; 43: 629-32
• 19 Babu R, Karikari IO, Owens TR, Bagley CA. Spinal cord astrocytomas: A modern 20-year experience at a single institution. Spine (Phila Pa 1976) 2014; 39: 533-40
• 20 Ahmed R, Menezes AH, Torner JC. Role of resection and adjuvant therapy in long-term disease outcomes for low-grade pediatric intramedullary spinal cord tumors. J Neurosurg Pediatr 2016; 18: 594-601
• 21 Hsu W, Jallo GI. Pediatric spinal tumors. In: Dulac O, Lassonde M, Sarnat HB. editors Handbook of Clinical Neurology. Part. 2. Vol. 112. Ch. 100. Amsterdam, The Netherlands: Elsevier; 2013: 959-65
• 22 Newton HB. Overview of pathology and treatment of primary spinal cord tumors. In: Handbook of Neuro-Oncology Neuroimaging. 2nd ed. Ch. 5 San Diego: Academic Press; 2016: 41-53
• 23 Xiao R, Miller JA, Abdullah KG, Lubelski D, Mroz TE, Benzel EC. et al. Quality of life outcomes following resection of adult intramedullary spinal cord tumors. Neurosurgery 2016; 78: 821-8